Patent · US Active

Peanut formulations and used thereof

US10512686B2 · kind B2 · utility

6Cited by
4References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2019
Grant dateDec 24, 2019
Priority date
Expiry dateFeb 28, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.